Company intelligence / Profile preview
MT-MicroSearch
Denmarkmt-microsearch.dk ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
MT-MicroSearch Aps produced bacterial mixtures for fecal microbiota transplantation that were directly administered to patients in clinical research settings. In at least one published study, their product was used to treat recurrent C. difficile infection with positive outcomes reported regarding efficacy and safety compared to other interventions over long-term follow-up.[10]
- Therapeutic areas
- GastroenterologyInfectious Diseases
- Modalities
- Fecal microbiota transplant (FMT)Bacterial mixtures for therapeutic use
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Not specified; likely collaborates with academic medical centers and hospitals conducting clinical trials using their products.[10]
Beyond the preview
Go deeper on MT-MicroSearch.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on MT-MicroSearch.